Hematopoietic stem cell transplantation

Haploidentical Transplantation With Pre-Transplant Immunosuppressive Therapy for Patients With Sickle Cell Disease

Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation

A Research Study of Bone Marrow Transplantation From Unrelated or Partially Matched Related Donors

A Study Comparing Allogeneic Hematopoietic Cell Transplantation Versus Best Available Standard of Care Therapy in Elderly Patients With Acute Myeloid Leukemia

Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia

Outpatient Hematopoietic Grafting in Multiple Sclerosis Employing Autologous Peripheral Blood Stem Cells

Hematopoietic Cell Transplantation for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors

Evaluating the Safety and Effectiveness of Bone Marrow Transplants in Children With Sickle Cell Disease (BMT CTN 0601)

Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi Anemia

Cytoxan, Fludara, and Antithymocyte Globulin Conditioning Followed By Stem Cell Transplant in Treating Fanconi Anemia

HSCT For Patients With High Risk Hemoglobinopathies Using Reduced Intensity

Gender Differences in Pediatric Hematopoietic Stem Cell Transplantation (HSCT)

Microbiome Alterations in IL10RA-deficient Patients After HSCT

Hematopoietic Stem Cell Transplantation in Chronic Inflammatory Demyelinating Polyneuropathy

Hematopoietic Stem Cell Transplant in Devic's Disease

Cyclophosphamide and Rabbit Antithymocyte Globulin (rATG)/Rituximab in Patients With Systemic Lupus Erythematosus

Chemo Sensitization Before Hematopoietic Stem Cell Transplantation in Patients With Acute Leukemia in Complete Remission

HSCT for High Risk Inherited Inborn Errors

SCT in Ph Positive Acute Lymphoblastic Leukemia

Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia Gravis